HonorHealth, a Valley healthcare system serving more than five million people in the greater Phoenix and Scottsdale areas, performed the first commercial case in Arizona using the FDA-approved Gore Excluder Thoracoabdominal Branch Endoprosthesis. 

This advanced technique, known as TAMBE, offers timely and effective complex aneurysm repair by placing a stent graft inside the aorta through small incisions in the body as an alternative to open surgery and incisions in the chest or abdomen, a press release explained.

“When an aneurysm rupture occurs, it often leads to a fatal or life-threatening event that requires surgery,” Dr. Hasan Aldailami, network director of vascular surgery at HonorHealth Heart Care, state in the release. 

TAMBE, according to Aldailami, is the first FDA-approved endovascular repair solution to treat complex aneurysms that involve the visceral aorta. A less invasive technique, TAMBE provides shorter hospital stays and a faster recovery.

Chief of Vascular Surgery at HonorHealth Scottsdale Osborn Medical Center and Divisional Director of Research and Innovation at HonorHealth Heart Care Dr. Venkatesh Ramaiah added that the HonorHealth Aortic Program is always looking to innovate a deliver the latest technology to treat aortic disease.

“It’s been a privilege to see HonorHealth at the forefront of innovation and research in the vascular space from 3D image-guided technology, revolutionary stents and now, breakthroughs in complex aortic aneurysms,” Ramaiah stated in the release.

Additionally, Aldailami and Ramaiah were part of the multi-disciplinary team that completed the first procedure at HonorHealth Scottsdale Shea Medical Center in July 2024.